Advertisement

Botulism: “I don’t need to talk, but I do need to swallow!”

  • Daniel Z. Adams
  • Colin G. Kaide
Chapter

Abstract

Botulism is a rare, toxin-mediated neurological illness characterized by acute descending flaccid paralysis affecting motor and autonomic function without sensory involvement. Common initial presenting symptoms in adults include the “four D’s” (diplopia, dysarthria, dysphagia, dry mouth). Cranial nerve paralysis can lead to difficulty swallowing and handling secretions. Ultimately, motor paralysis can lead to respiratory failure and the need for mechanical ventilation. Infants and children may present with more subtle features, especially in the very young patient who may only present with constipation or difficulty feeding. As noted, clusters can arise in conjunction with foodborne outbreaks; hence, a high clinical suspicion is needed when multiple individuals are affected. Diagnosis is presumptive while awaiting definitive toxin assay results, though often times, the assay may be negative regardless. EMG may also be helpful. In the meantime, however, attention needs to be given to identification of airway compromise from bulbar dysfunction/paralysis and respiratory fatigue requiring mechanical ventilation.

Keywords

Botulism Wound botulism Paralysis BOTOX Clostridium botulinum 

Notes

Disclosure Statement

Daniel Adams: Nothing to disclose

Colin Kaide: Callibra, Inc.-Discharge 123 medical software company. Medical Advisory Board Portola Pharmaceuticals. I have no relationship with a commercial company that has a direct financial interest in subject matter or materials discussed in article or with a company making a competing product.

References

  1. 1.
    Ganti L, Rastogi V. Acute generalized weakness. Emerg Med Clin North Am. 2016;34(4):795–809.CrossRefGoogle Scholar
  2. 2.
    Brook I. Botulism: the challenge with diagnosis and treatment. Rev Neurol Dis. 2006 Fall;3(4):182–9.PubMedGoogle Scholar
  3. 3.
    Sugiyama H. Clostridium botulinum neurotoxin. Microbiol Rev. 1980;44(3):419–48.PubMedPubMedCentralGoogle Scholar
  4. 4.
    McCarty CL, Angelo K, Beer KD, et al. Large outbreak of botulism associated with a church potluck meal – Ohio, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(29):802–3.CrossRefGoogle Scholar
  5. 5.
    Hughes JM, Blumenthal JR, Merson MH, et al. Clinical features of types A and B food-borne botulism. Ann Intern Med. 1981;95:442–5.CrossRefGoogle Scholar
  6. 6.
    Long SS. Infant botulism. Pediatr Infect Dis J. 2001;20(7):707.CrossRefGoogle Scholar
  7. 7.
    Rao AK, Lin NH, Griese SE, et al. Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks. Clin Infect Dis. 2018;66(suppl_1):S38.CrossRefGoogle Scholar
  8. 8.
    Rao AK, Lin NH, Jackson KA, Mody RK, Griffin PM. Clinical characteristics and ancillary test results among patients with botulism – United States, 2002-2015. Clin Infect Dis. 2017;66(suppl_1):S4.CrossRefGoogle Scholar
  9. 9.
    Hodowanec A, Bleck TP. Clostridium botulinum (Botulism). In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philidelphia: Elsevier Saunders; 2015. p. 2763.Google Scholar
  10. 10.
    American Academy of Pediatrics. Botulism and infant botulism (Clostridium botulinum). In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 294.Google Scholar
  11. 11.
    Lo YL. Clinical and immunological spectrum of the Miller-Fisher syndrome. Muscle Nerve. 2007;36(5):615–27.CrossRefGoogle Scholar
  12. 12.
    Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255:57–65.CrossRefGoogle Scholar
  13. 13.
    Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Contemporary Neurology Series. F.A. Davis Company. 1991.Google Scholar
  14. 14.
    Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285(8):1059–70.CrossRefGoogle Scholar
  15. 15.
    Wenham TN, Kensington C, Moor L. Botulism: a rare complication of injection drug use. Emerg Med J. 2008;25:55–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Daniel Z. Adams
    • 1
  • Colin G. Kaide
    • 2
  1. 1.Department of Pulmonology and Critical Care Medicine, Washington University/Barnes-Jewish HospitalSt. LouisUSA
  2. 2.Department of Emergency Medicine, Wexner Medical Center at The Ohio State UniversityColumbusUSA

Personalised recommendations